TY - JOUR
KW - Addiction outreach program
KW - Adult
KW - Aged
KW - Assisted outpatient treatment
KW - buprenorphine maintenance treatment
KW - Buprenorphine, Naloxone Drug Combination/adverse effects/therapeutic use
KW - buprenorphine-naloxone
KW - Drug Administration Schedule
KW - Female
KW - Hard-to-reach
KW - Harm Reduction
KW - Humans
KW - Male
KW - Medically assisted treatment
KW - Middle Aged
KW - Norway
KW - Opiate Substitution Treatment
KW - opioid maintenance treatment
KW - Opioid replacement therapy
KW - Opioid substitution therapy
KW - Out-reach program
KW - Outpatients
KW - Suboxone(R)
KW - Time-to-Treatment
KW - Treatment Outcome
KW - Young Adult
AU - K. Henriksen
AU - J. A. Jacobsen
AU - E. M. Henriksen
AU - L. Gomes
AU - H. Waal
AU - P. Krajci
A1 - 
BT - European addiction research
C5 - Opioids & Substance Use
CP - 6
CY - Switzerland
DO - 10.1159/000495188
IS - 6
JF - European addiction research
PB - S. Karger AG, Basel
PP - Switzerland
PY - 2018
SN - 1421-9891; 1022-6877
SP - 286
EP - 292
EP - 
T1 - The LASSO Program in Oslo: Harm Reduction Using Buprenorphine-Naloxone (Suboxone(R)) in a Low Threshold Setting
T2 - European addiction research
TI - The LASSO Program in Oslo: Harm Reduction Using Buprenorphine-Naloxone (Suboxone(R)) in a Low Threshold Setting
U1 - Opioids & Substance Use
U2 - 30466108
U3 - 10.1159/000495188
VL - 24
VO - 1421-9891; 1022-6877
Y1 - 2018
ER -